On the public citation graph

Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens

0 signed · 87 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s00428-010-0952-2openalex-snapshot
HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
inferredcites →https://doi.org/10.1007/s00428-014-1597-3openalex-snapshot
Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma
inferredcites →https://doi.org/10.1007/s10120-014-0453-0openalex-snapshot
HER2 testing in paired biopsy and excision specimens of gastric cancer: the reliability of the scoring system and the clinicopathological factors relevant to discordance
inferredcites →https://doi.org/10.1007/s10549-012-2046-0openalex-snapshot
Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance
inferredcites →https://doi.org/10.1007/s10620-012-2357-3openalex-snapshot
Are Biopsy Specimens Predictive of HER2 Status in Gastric Cancer Patients?
inferredcites →https://doi.org/10.1007/s12013-011-9286-1openalex-snapshot
Intratumoral Heterogeneity Determines Discordant Results of Diagnostic Tests for Human Epidermal Growth Factor Receptor (HER) 2 in Gastric Cancer Specimens
inferredcites →https://doi.org/10.1016/j.humpath.2013.12.010openalex-snapshot
Matched biopsy and resection specimens of gastric and gastroesophageal adenocarcinoma show high concordance in HER2 status
inferredcites →https://doi.org/10.1016/j.jamcollsurg.2012.09.007openalex-snapshot
Does Breast Tumor Heterogeneity Necessitate Further Immunohistochemical Staining on Surgical Specimens?
inferredcites →https://doi.org/10.1016/s0140-6736(10)61121-xopenalex-snapshot
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
inferredcites →https://doi.org/10.1038/modpathol.2011.198openalex-snapshot
HER2 testing in gastric cancer: a practical approach
inferredcites →https://doi.org/10.1038/modpathol.2011.206openalex-snapshot
‘Genetic heterogeneity' in HER2/neu testing by fluorescence in situ hybridization: a study of 2522 cases
inferredcites →https://doi.org/10.1038/modpathol.2012.205openalex-snapshot
Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas
inferredcites →https://doi.org/10.1038/modpathol.2012.36openalex-snapshot
Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
inferredcites →https://doi.org/10.1093/annonc/mdt393openalex-snapshot
Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR study
inferredcites →https://doi.org/10.1093/jnci/77.5.1047openalex-snapshot
Expression of Epidermal Growth Factor Receptors on Normal Human Gastric Epithelia and Gastric Carcinomas
inferredcites →https://doi.org/10.1111/ajco.12263openalex-snapshot
Human epidermal growth factor receptor 2 testing in gastric cancer: Recommendations of an A sia‐ P acific T ask F orce
inferredcites →https://doi.org/10.1111/j.1365-2559.2011.04017.xopenalex-snapshot
Human epidermal growth factor receptor 2 testing in gastric carcinoma: issues related to heterogeneity in biopsies and resections*
inferredcites →https://doi.org/10.1128/mcb.6.3.955openalex-snapshot
Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line.
inferredcites →https://doi.org/10.1136/jclinpath-2011-200345openalex-snapshot
HER2 status in unusual histological variants of gastric adenocarcinomas
inferredcites →https://doi.org/10.1158/1538-7445.am2014-2874openalex-snapshot
Abstract 2874: A prospective study of a repeat endoscopic biopsy to identify HER2-positive tumors following an initial HER2-negative endoscopic biopsy in unresectable or metastatic gastric cancer patients: GASTHER1 study
inferredcites →https://doi.org/10.1159/000353099openalex-snapshot
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
inferredcites →https://doi.org/10.1200/jco.2013.48.9070openalex-snapshot
Level of HER2 Gene Amplification Predicts Response and Overall Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab
inferredcites →https://doi.org/10.1245/s10434-012-2818-0openalex-snapshot
A Large Cohort of Consecutive Patients Confirmed Frequent HER2 Positivity in Gastric Carcinomas with Advanced Stages
inferredcites →https://doi.org/10.1593/tlo.12334openalex-snapshot
The Reliability of Endoscopic Biopsies in Assessing HER2 Status in Gastric and Gastroesophageal Junction Cancer: A Study Comparing Biopsies with Surgical Samples
inferredcites →https://doi.org/10.2165/11205900-000000000-00000openalex-snapshot
Trastuzumab
inferredcites →https://doi.org/10.5858/2007-131-18-asoccoopenalex-snapshot
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4667606openalex-extracted
Prediction of the Optimal Number of Tumor Blocks for Her2 Assessment in Gastric Carcinoma Resection Specimens: From Clinical Data to Mathematical Model Simulations
inferred← citeshttps://doi.org/10.1002/cnr2.70646openalex-snapshot
Human Epidermal Growth Factor Receptor 2‐Positive, Claudin‐18 Isoform 2‐Positive, Mismatch Repair‐Deficient Gastric Cancer Revealed by Immunohistochemical Analysis of Surgical Specimens: A Case Report
inferred← citeshttps://doi.org/10.1002/jhbp.445openalex-snapshot
A primary tumor of mixed histological type is a novel poor prognostic factor for patients undergoing resection of liver metastasis from gastric cancer
inferred← citeshttps://doi.org/10.1007/s10120-018-0887-xopenalex-snapshot
Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer
inferred← citeshttps://doi.org/10.1007/s10120-023-01417-xopenalex-snapshot
Down-regulation of stimulator of interferon genes (STING) expression and CD8+ T-cell infiltration depending on HER2 heterogeneity in HER2-positive gastric cancer
inferred← citeshttps://doi.org/10.1007/s10120-024-01505-6openalex-snapshot
Claudin-18 status and its correlation with HER2 and PD-L1 expression in gastric cancer with peritoneal dissemination
inferred← citeshttps://doi.org/10.1007/s12094-026-04359-9openalex-snapshot
HER2 discordance between primary and metastatic gastric cancer: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s12253-017-0276-5openalex-snapshot
Discordance Rate of HER2 Status in Primary Gastric Cancer and Synchronous Lymph Node Metastases: Its Impact on Therapeutic Decision and Clinical Management
inferred← citeshttps://doi.org/10.1007/s13691-025-00827-1openalex-snapshot
HER2 reassessment triggered by comprehensive genomic profiling reveals a therapeutic opportunity in refractory gastric cancer: a case report
inferred← citeshttps://doi.org/10.1016/j.bbcan.2021.188549openalex-snapshot
HER2-targeted therapies in gastric cancer
inferred← citeshttps://doi.org/10.1016/j.ejca.2017.01.015openalex-snapshot
Letter to the Editor regarding the paper by Park et al., Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)
inferred← citeshttps://doi.org/10.1016/j.ejca.2017.10.032openalex-snapshot
HER2 copy number of circulating tumour DNA functions as a biomarker to predict and monitor trastuzumab efficacy in advanced gastric cancer
inferred← citeshttps://doi.org/10.1016/j.esmoop.2024.104000openalex-snapshot
Clinicopathological analysis of claudin 18.2 focusing on intratumoral heterogeneity and survival in patients with metastatic or unresectable gastric cancer
inferred← citeshttps://doi.org/10.1016/j.jlb.2025.100288openalex-snapshot
Liquid biopsy in gastric cancer: A snapshot of the current state of the art
inferred← citeshttps://doi.org/10.1016/j.jmoldx.2019.02.007openalex-snapshot
Tumor Heterogeneity Index to Detect Human Epidermal Growth Factor Receptor 2 Amplification by Next-Generation Sequencing
inferred← citeshttps://doi.org/10.1016/j.jncc.2023.02.003openalex-snapshot
Assessment of the expression pattern of HER2 and its correlation with HER2-targeting antibody-drug conjugate therapy in urothelial cancer
inferred← citeshttps://doi.org/10.1016/j.modpat.2025.100753openalex-snapshot
Spatial Expression of HER2, NECTIN4, and TROP-2 in Muscle-Invasive Bladder Cancer and Metastases: Implications for Pathological and Clinical Management
inferred← citeshttps://doi.org/10.1016/j.molmet.2020.01.017openalex-snapshot
De novo discovery of metabolic heterogeneity with immunophenotype-guided imaging mass spectrometry
inferred← citeshttps://doi.org/10.1016/j.pathol.2017.05.009openalex-snapshot
HER2 testing in advanced gastric and gastro-oesophageal cancer: analysis of an Australia-wide testing program
inferred← citeshttps://doi.org/10.1016/j.prp.2020.152882openalex-snapshot
The age variation of HER2 immunohistochemistry positive rate in biopsy specimens of gastric cancer
inferred← citeshttps://doi.org/10.1016/j.prp.2020.153229openalex-snapshot
Intratumoral and intertumoral heterogeneity of HER2 immunohistochemical expression in gastric cancer
inferred← citeshttps://doi.org/10.1038/s41416-019-0399-4openalex-snapshot
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer
inferred← citeshttps://doi.org/10.1038/s41571-021-00492-2openalex-snapshot
Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm
inferred← citeshttps://doi.org/10.1038/s41598-017-03304-9openalex-snapshot
Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis
inferred← citeshttps://doi.org/10.1055/s-0043-116493openalex-snapshot
Gute Remission unter HER2-Blockade bei einem fortgeschrittenen Karzinom des ösophagogastralen Überganges bei nur fokaler HER2-Überexpression
inferred← citeshttps://doi.org/10.1093/annonc/mdx685openalex-snapshot
A novel pretherapeutic gene expression-based risk score for treatment guidance in gastric cancer
inferred← citeshttps://doi.org/10.1093/oncolo/oyaf037openalex-snapshot
Ramucirumab and paclitaxel in second or greater lines of therapy in patients with HER2-positive gastroesophageal cancer: a single center study
inferred← citeshttps://doi.org/10.1097/cej.0000000000000788openalex-snapshot
Cytoplasmic poly(A)-binding protein 1 as a biomarker to assist early diagnosis and prognosis of esophageal squamous cell carcinoma in endoscopic biopsy fragments
inferred← citeshttps://doi.org/10.1097/pas.0000000000000756openalex-snapshot
High-throughput Protein and mRNA Expression–based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications
inferred← citeshttps://doi.org/10.1097/pas.0000000000002464openalex-snapshot
Claudin 18.2 and Other Therapeutic Biomarkers in Gastric and Gastroesophageal Junction Adenocarcinomas
inferred← citeshttps://doi.org/10.1111/cas.13314openalex-snapshot
Circulating tumor DNA functions as an alternative for tissue to overcome tumor heterogeneity in advanced gastric cancer
inferred← citeshttps://doi.org/10.1111/his.13257openalex-snapshot
HER 2 assessment in locally advanced gastric cancer: comparing the results obtained with the use of two primary tumour blocks versus those obtained with the use of all primary tumour blocks
inferred← citeshttps://doi.org/10.1111/his.13816openalex-snapshot
Upper GI biopsies for adenocarcinoma – how many biopsies should endoscopists take?
inferred← citeshttps://doi.org/10.1158/2159-8290.cd-17-0395openalex-snapshot
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
inferred← citeshttps://doi.org/10.1177/17588359241287747openalex-snapshot
A biopsy-based Immunoscore in patients with treatment-naïve resectable gastric cancer
inferred← citeshttps://doi.org/10.1186/s13000-017-0616-5openalex-snapshot
Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer
inferred← citeshttps://doi.org/10.1186/s13000-022-01230-7openalex-snapshot
Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer: a prospective multicenter clinical trial from China
inferred← citeshttps://doi.org/10.1200/jco.20.02761openalex-snapshot
HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study
inferred← citeshttps://doi.org/10.1200/po-25-01194openalex-snapshot
Concordance of Circulating Tumor DNA, Primary and Metastatic Tissue DNA, and Immunohistochemistry in Gastroesophageal Carcinoma
inferred← citeshttps://doi.org/10.12998/wjcc.v7.i15.1964openalex-snapshot
HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer
inferred← citeshttps://doi.org/10.12998/wjcc.v7.i4.419openalex-snapshot
Formalin fixation on HER-2 and PD-L1 expression in gastric cancer: A pilot analysis using the same surgical specimens with different fixation times
inferred← citeshttps://doi.org/10.17650/1726-9784-2019-19-2-6-12openalex-snapshot
CURRENT POINT OF VIEW ON PROGNOSTIC AND PREDICTIVE ROLES AND PRACTICAL APPLICATION OF HER2 RECEPTOR’S DETECTION. LITERATURE REVIEW
inferred← citeshttps://doi.org/10.18632/oncotarget.16567openalex-snapshot
Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type
inferred← citeshttps://doi.org/10.18632/oncotarget.25507openalex-snapshot
The dynamics of HER2 status in esophageal adenocarcinoma
inferred← citeshttps://doi.org/10.18632/oncotarget.8145openalex-snapshot
Associations between serum CA724 and HER2 overexpression among stage II-III resectable gastric cancer patients: an observational study
inferred← citeshttps://doi.org/10.21203/rs.3.rs-944694/v1openalex-snapshot
Dual Block HER2 Assessment Increased HER2 Immunohistochemistry Positive Rate in Resected Specimens of Gastric Cancer: A Prospective Multicenter Clinical Trial From China
inferred← citeshttps://doi.org/10.2147/ott.s100643openalex-snapshot
Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives
inferred← citeshttps://doi.org/10.23838/pfm.2017.00079openalex-snapshot
Biomarkers for gastric cancer: molecular classification revisited
inferred← citeshttps://doi.org/10.3346/jkms.2023.38.e255openalex-snapshot
Sample Collection Methods in Upper Gastrointestinal Research
inferred← citeshttps://doi.org/10.3390/biomedicines10030543openalex-snapshot
Gastric Cancer: Mechanisms, Biomarkers, and Therapeutic Approaches
inferred← citeshttps://doi.org/10.3390/jcm12144646openalex-snapshot
Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives
inferred← citeshttps://doi.org/10.3390/medicina62040683openalex-snapshot
Comprehensive Overview of Gastric Cancer Immunohistochemistry: Key Biomarkers, Advanced Detection Methods, and Perspectives
inferred← citeshttps://doi.org/10.3748/wjg.v22.i19.4619openalex-snapshot
HER2 testing in gastric cancer: An update
inferred← citeshttps://doi.org/10.3748/wjg.v22.i26.5879openalex-snapshot
HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice
inferred← citeshttps://doi.org/10.38103/jcmhch.2021.69.10openalex-snapshot
Her2 status in gastric adenocarcinoma: comparison between matched endoscopic biopsy and gastrectomy specimens
inferred← citeshttps://doi.org/10.3892/etm.2019.7409openalex-snapshot
LncRNA GASL1 inhibits tumor growth in gastric carcinoma by inactivating the Wnt/β‑catenin signaling pathway
inferred← citeshttps://doi.org/10.4132/jptm.2022.12.23openalex-snapshot
A standardized pathology report for gastric cancer: 2nd edition
inferred← citeshttps://doi.org/10.5230/jgc.2023.23.e7openalex-snapshot
A Standardized Pathology Report for Gastric Cancer: 2nd Edition
inferred← citeshttps://doi.org/10.5230/jgc.2024.24.e6openalex-snapshot
Emerging Targets for Systemic Treatment of Gastric Cancer: HER2 and Beyond
inferred← citeshttps://doi.org/10.5230/jgc.2025.25.e3openalex-snapshot
Spatial and Temporal Tumor Heterogeneity in Gastric Cancer: Discordance of Predictive Biomarkers
inferred← citeshttps://doi.org/10.62546/3034-1477-2024-2-3-7-17openalex-snapshot
Problematic aspects of assessing predictive markers for gastric cancer based on endoscopic biopsy samples. Review
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.